Centiva Capital’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-12,669
Closed -$266K 1994
2024
Q4
$266K Buy
+12,669
New +$293K 0.01% 1213
2024
Q2
Sell
-10,818
Closed -$140K 2399
2024
Q1
$140K Sell
10,818
-6,945
-39% -$83.2K ﹤0.01% 1559
2023
Q4
$206K Buy
+17,763
New +$200K ﹤0.01% 1420

Other funds holding PAHC

Centiva Capital's PAHC Position: Q1 2025 in Review

Centiva Capital sold out of Phibro Animal Health (PAHC) in Q1 2025, closing a stake of 12,669 shares — an estimated $266K sold.

Centiva Capital first reported a position in PAHC in Q4 2023 and held it in 3 quarters. The position peaked at $266K in Q4 2024. 182 funds tracked by Wall St. Rank hold PAHC as of Q1 2025.

  • Centiva Capital reported no remaining Phibro Animal Health position as of Q1 2025 after selling out during the quarter.
  • Centiva Capital sold 12,669 Phibro Animal Health shares in Q1 2025, an estimated $266K.
  • Centiva Capital first reported a position in Phibro Animal Health in Q4 2023 and held it in 3 quarters.
  • Centiva Capital's Phibro Animal Health position peaked at $266K in Q4 2024.
  • 182 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2025.

Based on Centiva Capital's 13F filing for Q1 2025, filed 15 May 2025.